bluebird bio 2023 J.P. Morgan investor presentation

bluebird bio presented to investors at the J.P. Morgan Healthcare Conference in January 2023, discussing their gene therapy programs and commercialization plans. The company outlined expectations for regulatory filings, manufacturing strategy, and addressable market opportunities for their pipeline of product candidates.